• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情:流行病学与临床视角

The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective.

作者信息

Wong Rebecca S Y

机构信息

Faculty of Medicine, SEGi University, No. 9, Jalan Teknologi, Taman Sains Selangor, Kota Damansara, PJU 5, 47810 Petaling Jaya, Selangor Malaysia.

出版信息

SN Compr Clin Med. 2020;2(11):1983-1991. doi: 10.1007/s42399-020-00546-z. Epub 2020 Sep 29.

DOI:10.1007/s42399-020-00546-z
PMID:33015553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524027/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak started with the detection of an increasing number of pneumonia cases of unknown origin in Wuhan, China, since December 2019. The disease caused by SAS-CoV-2 was subsequently named coronavirus disease 2019 (COVID-19). Currently, the ongoing COVID-19 pandemic poses a global health concern with more than 28.9 million confirmed cases, taking away the lives of more than 900,000 people worldwide. To prevent further spread of the disease, an understanding of the clinical characteristics and how the disease spread is essential, especially for an emerging disease like COVID-19. Individuals who are infected with SARS-CoV-2 show diverse clinical features, and the disease severity can range from asymptomatic to death. The disease has been shown to affect not just the respiratory system but also other systems of the body. This review will discuss the pulmonary and extra-pulmonary clinical manifestations of COVID-19 in general, as well as the clinical characteristics in different groups of patients such as children, the elderly, pregnant women, patients with comorbidities and those with a compromised immunity. It will also critically examine existing evidence from relevant studies and discuss the SARS-CoV-2 outbreak from an epidemiological perspective. With the easing of control measures in many countries after months of lockdown, it is important to revisit the lessons learnt from research, as the world enters a new normal with the coexistence of SARS-CoV-2.

摘要

自2019年12月以来,中国武汉发现了越来越多不明原因的肺炎病例,由此引发了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情。随后,由SARS-CoV-2引起的疾病被命名为2019冠状病毒病(COVID-19)。目前,仍在肆虐的COVID-19疫情引发了全球对健康问题的关注,确诊病例超过2890万例,全球死亡人数超过90万。为防止该疾病进一步传播,了解其临床特征以及传播方式至关重要,对于像COVID-19这样的新兴疾病尤其如此。感染SARS-CoV-2的个体表现出多样的临床特征,疾病严重程度从无症状到死亡不等。已证明该疾病不仅会影响呼吸系统,还会影响身体的其他系统。本综述将总体讨论COVID-19的肺部和肺外临床表现,以及不同患者群体(如儿童、老年人、孕妇、合并症患者和免疫功能低下者)的临床特征。它还将严格审查相关研究的现有证据,并从流行病学角度讨论SARS-CoV-2疫情。在经历数月封锁后,许多国家放松了管控措施,随着世界进入SARS-CoV-2共存的新常态,重新审视从研究中吸取的教训很重要。

相似文献

1
The SARS-CoV-2 Outbreak: an Epidemiological and Clinical Perspective.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情:流行病学与临床视角
SN Compr Clin Med. 2020;2(11):1983-1991. doi: 10.1007/s42399-020-00546-z. Epub 2020 Sep 29.
2
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
3
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
4
COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.新型冠状病毒肺炎:一场全球性的人畜共患病大流行疫情。
Altern Ther Health Med. 2020 Aug;26(S2):56-64.
5
The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.疫情初期防控措施下新型冠状病毒在中国的空间传播。
Arch Public Health. 2021 Jan 13;79(1):8. doi: 10.1186/s13690-021-00529-z.
6
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
7
SARS-CoV-2 and COVID-19: A perspective from environmental virology.严重急性呼吸综合征冠状病毒2与冠状病毒病:环境病毒学视角
Genet Mol Biol. 2021 Mar 8;44(1 Suppl 1):e20200228. doi: 10.1590/1678-4685-GMB-2020-0228. eCollection 2021.
8
Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.冠状病毒疾病与妊娠:新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征
Przegl Epidemiol. 2020;74(2):276-289. doi: 10.32394/pe.74.21.
9
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.概述:严重急性呼吸系统综合征的历史和儿科视角:新型还是类似 SARS。
Pediatr Pulmonol. 2020 Jul;55(7):1584-1591. doi: 10.1002/ppul.24810. Epub 2020 Jun 1.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Peripheral nervous system involvement associated with COVID-19. A systematic review of literature.与 COVID-19 相关的周围神经系统受累。文献系统综述。
PLoS One. 2023 Apr 6;18(4):e0283827. doi: 10.1371/journal.pone.0283827. eCollection 2023.
2
Knowledge, Attitudes and Practices of the General Population in Yemen Regarding COVID-19: A Cross-Sectional Study.也门普通民众对新冠病毒的认知、态度和行为:一项横断面研究。
Diseases. 2023 Jan 26;11(1):17. doi: 10.3390/diseases11010017.
3
Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗诱导的垂体疾病的初步研究结果:从诊断到病理生理学的小型综述
Vaccines (Basel). 2022 Nov 24;10(12):2004. doi: 10.3390/vaccines10122004.
4
Lessons from SARS‑CoV‑2 and its variants (Review).SARS-CoV-2 及其变体的教训(综述)。
Mol Med Rep. 2022 Aug;26(2). doi: 10.3892/mmr.2022.12779. Epub 2022 Jun 22.
5
Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients.锂治疗对新冠病毒感染患者的疗效与安全性
Front Pharmacol. 2022 Apr 14;13:850583. doi: 10.3389/fphar.2022.850583. eCollection 2022.
6
Extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: a pocket guide for radiologists.COVID-19 患者体外膜肺氧合(ECMO):放射科医生袖珍指南。
Radiol Med. 2022 Apr;127(4):369-382. doi: 10.1007/s11547-022-01473-w. Epub 2022 Mar 13.
7
COVID-19 prediction through X-ray images using transfer learning-based hybrid deep learning approach.使用基于迁移学习的混合深度学习方法通过X射线图像进行COVID-19预测。
Mater Today Proc. 2022;51:2520-2524. doi: 10.1016/j.matpr.2021.12.123. Epub 2021 Dec 13.
8
Inflammation in COVID-19: from pathogenesis to treatment.新型冠状病毒肺炎中的炎症:从发病机制到治疗
Int J Clin Exp Pathol. 2021 Jul 15;14(7):831-844. eCollection 2021.
9
Geographical and Epidemiological Characteristics of Sporadic Coronavirus Disease 2019 Outbreaks From June to December 2020 in China: An Overview of Environment-To-Human Transmission Events.2020年6月至12月中国散发性新型冠状病毒肺炎疫情的地理和流行病学特征:环境到人的传播事件概述
Front Med (Lausanne). 2021 Jul 16;8:654422. doi: 10.3389/fmed.2021.654422. eCollection 2021.
10
SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.SARS-CoV-2:起源、进化与靶向抑制。
Front Cell Infect Microbiol. 2021 Jun 17;11:676451. doi: 10.3389/fcimb.2021.676451. eCollection 2021.

本文引用的文献

1
Serial Interval and Reproductive Number of COVID-19 Among 116 Infector-infectee Pairs - Jingzhou City, Hubei Province, China, 2020.2020年中国湖北省荆州市116对新冠病毒感染者-被感染者配对中的传播间隔和再生数
China CDC Wkly. 2020 Jul 3;2(27):491-495. doi: 10.46234/ccdcw2020.118.
2
Challenges in control of COVID-19: short doubling time and long delay to effect of interventions.控制 COVID-19 的挑战:短的倍增时间和干预效果的长延迟。
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200264. doi: 10.1098/rstb.2020.0264. Epub 2021 May 31.
3
Stability of SARS-CoV-2 in different environmental conditions.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在不同环境条件下的稳定性
Lancet Microbe. 2020 May;1(1):e10. doi: 10.1016/S2666-5247(20)30003-3. Epub 2020 Apr 2.
4
Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.新型冠状病毒肺炎孕妇的临床表现和结局:系统评价和荟萃分析。
Clin Infect Dis. 2021 Feb 1;72(3):521-533. doi: 10.1093/cid/ciaa828.
5
Toxic shock-like syndrome and COVID-19: Multisystem inflammatory syndrome in children (MIS-C).中毒性休克样综合征与 COVID-19:儿童多系统炎症综合征(MIS-C)。
Am J Emerg Med. 2020 Nov;38(11):2492.e5-2492.e6. doi: 10.1016/j.ajem.2020.05.117. Epub 2020 Jun 6.
6
Extrapulmonary and atypical clinical presentations of COVID-19.COVID-19 的肺外和非典型临床表现。
J Med Virol. 2020 Nov;92(11):2458-2464. doi: 10.1002/jmv.26157. Epub 2020 Jun 29.
7
Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study.法国巴黎新冠疫情期间儿童川崎样多系统炎症综合征:前瞻性观察研究。
BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.
8
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.中国湖北省癌症合并 COVID-19 患者的临床特征、结局和死亡危险因素:一项多中心、回顾性队列研究。
Lancet Oncol. 2020 Jul;21(7):904-913. doi: 10.1016/S1470-2045(20)30310-7. Epub 2020 May 29.
9
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.接受化疗或其他抗癌治疗的癌症患者的 COVID-19 死亡率:一项前瞻性队列研究。
Lancet. 2020 Jun 20;395(10241):1919-1926. doi: 10.1016/S0140-6736(20)31173-9. Epub 2020 May 28.
10
Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview.COVID-19 的肺外表现:影像学和临床概述。
Clin Imaging. 2020 Oct;66:35-41. doi: 10.1016/j.clinimag.2020.05.013. Epub 2020 May 18.